Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
July 23, 2008

Astellas Gains Morphosys’ Antibody Optimization Technology

  • Astellas Pharma exercised a pre-existing option to use MorphoSys’ RapMAT technology for antibody optimization. As part of the existing technology transfer agreements between the two companies, Astellas will thus have access to RapMAT alongside MorphoSys’ antibody library, HuCAL GOLD, at its research site in Tsukuba, Japan.